Entertainment
Compare Stocks
2 / 10Stock Comparison
CNVS vs CURI
Revenue, margins, valuation, and 5-year total return — side by side.
Broadcasting
CNVS vs CURI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Entertainment | Broadcasting |
| Market Cap | $52M | $181M |
| Revenue (TTM) | $55M | $72M |
| Net Income (TTM) | $-9M | $-6M |
| Gross Margin | 53.9% | 56.6% |
| Operating Margin | -12.5% | -10.2% |
| Forward P/E | 16.6x | 88.3x |
| Total Debt | $462K | $12M |
| Cash & Equiv. | $14M | $18M |
CNVS vs CURI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cineverse Corp. (CNVS) | 100 | 15.6 | -84.4% |
| CuriosityStream Inc. (CURI) | 100 | 31.6 | -68.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CNVS vs CURI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CNVS is the clearest fit if your priority is growth exposure.
- Rev growth 59.1%, EPS growth 109.0%, 3Y rev CAGR 11.7%
- 59.1% revenue growth vs CURI's 40.1%
- Lower P/E (16.6x vs 88.3x)
CURI carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 1.44, yield 12.4%
- -63.7% 10Y total return vs CNVS's -93.7%
- Lower volatility, beta 1.44, Low D/E 30.0%, current ratio 1.23x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 59.1% revenue growth vs CURI's 40.1% | |
| Value | Lower P/E (16.6x vs 88.3x) | |
| Quality / Margins | -9.0% margin vs CNVS's -16.7% | |
| Stability / Safety | Beta 1.44 vs CNVS's 1.44 | |
| Dividends | 12.4% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +6.4% vs CNVS's -5.3% | |
| Efficiency (ROA) | -8.2% ROA vs CNVS's -13.4%, ROIC -12.2% vs 20.3% |
CNVS vs CURI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CNVS vs CURI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CURI leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CURI and CNVS operate at a comparable scale, with $72M and $55M in trailing revenue. CURI is the more profitable business, keeping -9.0% of every revenue dollar as net income compared to CNVS's -16.7%. On growth, CURI holds the edge at +35.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $55M | $72M |
| EBITDAEarnings before interest/tax | -$2M | $14M |
| Net IncomeAfter-tax profit | -$9M | -$6M |
| Free Cash FlowCash after capex | -$13M | $13M |
| Gross MarginGross profit ÷ Revenue | +53.9% | +56.6% |
| Operating MarginEBIT ÷ Revenue | -12.5% | -10.2% |
| Net MarginNet income ÷ Revenue | -16.7% | -9.0% |
| FCF MarginFCF ÷ Revenue | -22.8% | +18.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -60.0% | +35.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -113.2% | -31.2% |
Valuation Metrics
CNVS leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, CNVS's 3.3x EV/EBITDA is more attractive than CURI's 23.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $52M | $181M |
| Enterprise ValueMkt cap + debt − cash | $39M | $176M |
| Trailing P/EPrice ÷ TTM EPS | 16.63x | -28.09x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 88.29x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 3.29x | 23.82x |
| Price / SalesMarket cap ÷ Revenue | 0.67x | 2.53x |
| Price / BookPrice ÷ Book value/share | 1.25x | 4.29x |
| Price / FCFMarket cap ÷ FCF | 3.21x | 14.01x |
Profitability & Efficiency
CNVS leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
CURI delivers a -13.1% return on equity — every $100 of shareholder capital generates $-13 in annual profit, vs $-24 for CNVS. CNVS carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CURI's 0.30x. On the Piotroski fundamental quality scale (0–9), CNVS scores 7/9 vs CURI's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -24.4% | -13.1% |
| ROA (TTM)Return on assets | -13.4% | -8.2% |
| ROICReturn on invested capital | +20.3% | -12.2% |
| ROCEReturn on capital employed | +22.3% | -13.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.01x | 0.30x |
| Net DebtTotal debt minus cash | -$13M | -$6M |
| Cash & Equiv.Liquid assets | $14M | $18M |
| Total DebtShort + long-term debt | $462,000 | $12M |
| Interest CoverageEBIT ÷ Interest expense | -4.16x | — |
Total Returns (Dividends Reinvested)
CURI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CURI five years ago would be worth $2,935 today (with dividends reinvested), compared to $1,090 for CNVS. Over the past 12 months, CURI leads with a +6.4% total return vs CNVS's -5.3%. The 3-year compound annual growth rate (CAGR) favors CURI at 54.0% vs CNVS's -26.1% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +26.7% | -15.7% |
| 1-Year ReturnPast 12 months | -5.3% | +6.4% |
| 3-Year ReturnCumulative with dividends | -59.7% | +265.4% |
| 5-Year ReturnCumulative with dividends | -89.1% | -70.6% |
| 10-Year ReturnCumulative with dividends | -93.7% | -63.7% |
| CAGR (3Y)Annualised 3-year return | -26.1% | +54.0% |
Risk & Volatility
CURI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CURI is the less volatile stock with a 1.44 beta — it tends to amplify market swings less than CNVS's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CURI currently trades 43.2% from its 52-week high vs CNVS's 36.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.44x | 1.44x |
| 52-Week HighHighest price in past year | $7.39 | $7.15 |
| 52-Week LowLowest price in past year | $1.77 | $2.81 |
| % of 52W HighCurrent price vs 52-week peak | +36.0% | +43.2% |
| RSI (14)Momentum oscillator 0–100 | 50.9 | 40.1 |
| Avg Volume (50D)Average daily shares traded | 145K | 346K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
CURI is the only dividend payer here at 12.35% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $3.67 |
| # AnalystsCovering analysts | — | 9 |
| Dividend YieldAnnual dividend ÷ price | — | +12.4% |
| Dividend StreakConsecutive years of raises | — | 2 |
| Dividend / ShareAnnual DPS | — | $0.38 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | 0.0% |
CURI leads in 3 of 6 categories (Income & Cash Flow, Total Returns). CNVS leads in 2 (Valuation Metrics, Profitability & Efficiency).
CNVS vs CURI: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is CNVS or CURI a better buy right now?
For growth investors, Cineverse Corp.
(CNVS) is the stronger pick with 59. 1% revenue growth year-over-year, versus 40. 1% for CuriosityStream Inc. (CURI). Cineverse Corp. (CNVS) offers the better valuation at 16. 6x trailing P/E, making it the more compelling value choice. Analysts rate CuriosityStream Inc. (CURI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CNVS or CURI?
Over the past 5 years, CuriosityStream Inc.
(CURI) delivered a total return of -70. 6%, compared to -89. 1% for Cineverse Corp. (CNVS). Over 10 years, the gap is even starker: CURI returned -63. 7% versus CNVS's -93. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CNVS or CURI?
By beta (market sensitivity over 5 years), CuriosityStream Inc.
(CURI) is the lower-risk stock at 1. 44β versus Cineverse Corp. 's 1. 44β — meaning CNVS is approximately 0% more volatile than CURI relative to the S&P 500. On balance sheet safety, Cineverse Corp. (CNVS) carries a lower debt/equity ratio of 1% versus 30% for CuriosityStream Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — CNVS or CURI?
By revenue growth (latest reported year), Cineverse Corp.
(CNVS) is pulling ahead at 59. 1% versus 40. 1% for CuriosityStream Inc. (CURI). On earnings-per-share growth, the picture is similar: Cineverse Corp. grew EPS 109. 0% year-over-year, compared to 54. 2% for CuriosityStream Inc.. Over a 3-year CAGR, CNVS leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CNVS or CURI?
Cineverse Corp.
(CNVS) is the more profitable company, earning 4. 6% net margin versus -9. 0% for CuriosityStream Inc. — meaning it keeps 4. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CNVS leads at 10. 1% versus -10. 2% for CURI. At the gross margin level — before operating expenses — CURI leads at 56. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — CNVS or CURI?
In this comparison, CURI (12.
4% yield) pays a dividend. CNVS does not pay a meaningful dividend and should not be held primarily for income.
07Is CNVS or CURI better for a retirement portfolio?
For long-horizon retirement investors, CuriosityStream Inc.
(CURI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (12. 4% yield). Both have compounded well over 10 years (CURI: -63. 7%, CNVS: -93. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between CNVS and CURI?
Both stocks operate in the Communication Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
CURI pays a dividend while CNVS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 17%
- Gross Margin > 33%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.
Compare CURI vs FUBO
FUBO is one of the most direct listed alternatives to CURI.
Compare CNVS vs FUBO
FUBO overlaps with CNVS in an adjacent operating segment worth comparing.
Expand With FUBO + AMCX
FUBO and AMCX are the strongest missing peers across the current compare set.